Roche immunotherapy drug shrinks tumors in early bladder cancer study

ZURICH (Reuters) – Roche’s experimental drug that spurs the immune system to fight cancer shrank tumors in 43 percent of people with a specific type of metastatic bladder cancer, according to results of an early-stage trial published on Saturday. The drug MPDL3280A is part of a…

Source:Roche immunotherapy drug shrinks tumors in early bladder cancer study